Its blsheet Insmed has a long approval process and a limited market as of Now.IF parameters of safety and application are acheived this biotech company can move forward.These highfalutin tales of riches are nonsense.
Its blsheet Insmed has a long approval process and a limited market as of Now.IF parameters of safety and application are acheived this biotech company can move forward.These highfalutin tales of riches are nonsense.
Terry, can you just come clean and tell us all why you spend every day trashing Insmed with ever new IDs? There must have been some traumatic event that can explain the constant negativity. Inquiring minds want to know. You are one for the books.